Indivior News

Former Indivior CEO Pleads Guilty in U.S. in Opioid Addiction Treatment Probe

Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Department investigation into the marketing of its opioid addiction treatment Suboxone. Thaxter pleaded guilty in federal …

Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug

A U.S. jury on Friday rejected a claim by Sweden’s Orexo AB that two generic opioid-addiction treatments created by Teva Pharmaceutical Industries Ltd. infringed a patent for Orexo’s biggest drug, Zubsolv. A Teva unit had created copies of the drugs …